I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2026 Q1, the actual value is USD 14.43 M.
EPS: As of FY2026 Q1, the actual value is USD -0.06.
EBIT: As of FY2026 Q1, the actual value is USD -8.316 M.
Segment Revenue
- OmniAb, Inc. reported total revenue of $14.4 million for the first quarter of 2026, a significant increase from $4.2 million for the same period in 2025, primarily driven by milestone revenue .
- License and milestone revenue was $12,025 thousand in Q1 2026, up from $2,021 thousand in Q1 2025 .
- Service revenue increased to $2,107 thousand from $1,903 thousand year-over-year .
- xPloration revenue rose to $54 thousand from $42 thousand year-over-year .
- Royalty revenue also increased to $241 thousand in Q1 2026, compared to $188 thousand in Q1 2025 .
Operational Metrics
- Net Loss: OmniAb, Inc.’s net loss for Q1 2026 was -$7.7 million, a substantial improvement from a net loss of -$18.2 million in Q1 2025 .
- Loss from Operations: Loss from operations improved to -$7,829 thousand in Q1 2026 from -$18,844 thousand in Q1 2025 .
- Operating Costs:
- Total costs and operating expenses were $22.3 million in Q1 2026, a slight decrease from $23.0 million in Q1 2025 .
- Cash costs and operating expenses (Non-GAAP) were $12.3 million in Q1 2026, down from $14.7 million in Q1 2025 .
- Research and development expense decreased to $9.6 million in Q1 2026 from $12.6 million in Q1 2025 .
- General and administrative expense decreased to $6.6 million in Q1 2026 from $7.9 million in Q1 2025 .
- Amortization of intangibles increased to $6.0 million in Q1 2026 from $3.2 million in Q1 2025, primarily due to a $2.9 million non-cash impairment .
Cash Flow
- Operating cash flow and free cash flow data are not explicitly provided in the reference .
Unique Metrics
- As of March 31, 2026, OmniAb, Inc. had 107 active partners and 409 active programs, including 32 OmniAb-derived programs in clinical development or being commercialized .
- During Q1 2026, OmniAb, Inc. entered into a new license agreement with Florida State University .
Other Key Financial Metrics
- Cash and Cash Equivalents: Increased to $29,046 thousand as of March 31, 2026, from $25,524 thousand as of December 31, 2025 .
- Short-term Investments: Were $20,026 thousand as of March 31, 2026, down from $28,501 thousand as of December 31, 2025 .
- Total Assets: Were $293,650 thousand as of March 31, 2026, compared to $300,914 thousand as of December 31, 2025 .
- Total Liabilities: Decreased to $31,004 thousand as of March 31, 2026, from $33,887 thousand as of December 31, 2025 .
- Total Stockholders’ Equity: Was $262,646 thousand as of March 31, 2026, decreasing from $267,027 thousand as of December 31, 2025 .
Outlook / Guidance
OmniAb, Inc. increased its 2026 revenue guidance to a range of $28 million to $33 million and expects total costs and operating expenses to be between $83 million and $88 million . The company anticipates ending 2026 with cash and cash equivalents in the range of $33 million to $38 million, projecting a full-year effective tax rate of approximately 0% .